Blog
New
Understanding Reproductive Genetics
Understanding Reproductive Genetics
Rita Bhui
5 Min Read
Share
Reproductive Genetics.
Reproductive genetics focuses on the genetic factors that influence fertility, conception, and the health of a developing fetus. It helps answer critical questions: Can a couple pass on a genetic condition? Is a pregnancy at risk for chromosomal abnormalities? How can IVF and embryo selection be optimized?
As maternal age increases and the understanding of inherited diseases improves, this field is becoming essential for preventing disease, reducing complications, and supporting healthier pregnancies.
Available Genetic Approaches
Non-Invasive Prenatal Testing (NIPT)
Analyzes fetal DNA in maternal blood to screen for chromosomal abnormalities.
Diagnostic Procedures (CVS & Amniocentesis)
Confirm genetic findings during pregnancy.
Preimplantation Genetic Testing (PGT)
Checks embryos created through IVF for chromosomal or gene-specific conditions before implantation.
Whole Exome/Genome Sequencing
Reveals underlying mutations in cases of recurrent pregnancy loss or unexplained infertility.
What Makes It Difficult?
Despite rapid advances, reproductive genetics faces major barriers:
Limited Coverage
Most panels test only a selected list of genes, missing rare variants, especially in diverse populations.
Scalability and Cost
Testing many genes separately is expensive. IVF with PGT adds significant financial pressure.
Turnaround Time
In pregnancy, time is critical. Delays in results affect important decisions. Labs need fast, reliable, high-capacity methods.
How AlgoBio Can Help
AlgoBio addresses these challenges through two complementary technologies:
Sequence Transduction for High-Throughput Variant Detection
Enables parallel analysis of many genetic markers in a single workflow. This allows comprehensive panels for carrier mutations, aneuploidy, PGT targets, and rare variants. Assay design is fully customizable for prenatal, fertility, or population screening.
Tapestry for Efficient Sample Pooling
Uses combinatorial pooling to test many individuals or embryos efficiently. Each sample is distributed across multiple structured pools, providing built-in confirmation and minimizing false positives.
Key Advantages:
• High-throughput testing with fewer reactions
• Reduced reagent use and lower costs
• Built-in cross-validation increases confidenceThis is ideal for carrier screening, IVF embryo testing, and large prenatal workloads.
Together, these technologies simplify workflows, enabling faster setup, scalable processing, accurate detection, and lower costs—making advanced genetic testing more accessible for clinical decisions.
The Future of Reproductive Genetics
Reproductive genetics is moving from specialized testing to routine clinical practice. Genetic screening before and during pregnancy is likely to become standard, helping families make informed decisions early.
By combining intelligent technology with deep biological insight, AlgoBio offers practical solutions to broaden testing, improve efficiency, and support healthier pregnancies. Sequence Transduction expands variant coverage, while Tapestry enables scalable testing—together, they provide a powerful foundation for the future of reproductive genetics.
More Article
Reproductive Genetics.
Reproductive genetics focuses on the genetic factors that influence fertility, conception, and the health of a developing fetus. It helps answer critical questions: Can a couple pass on a genetic condition? Is a pregnancy at risk for chromosomal abnormalities? How can IVF and embryo selection be optimized?
As maternal age increases and the understanding of inherited diseases improves, this field is becoming essential for preventing disease, reducing complications, and supporting healthier pregnancies.
Available Genetic Approaches
Non-Invasive Prenatal Testing (NIPT)
Analyzes fetal DNA in maternal blood to screen for chromosomal abnormalities.
Diagnostic Procedures (CVS & Amniocentesis)
Confirm genetic findings during pregnancy.
Preimplantation Genetic Testing (PGT)
Checks embryos created through IVF for chromosomal or gene-specific conditions before implantation.
Whole Exome/Genome Sequencing
Reveals underlying mutations in cases of recurrent pregnancy loss or unexplained infertility.
What Makes It Difficult?
Despite rapid advances, reproductive genetics faces major barriers:
Limited Coverage
Most panels test only a selected list of genes, missing rare variants, especially in diverse populations.
Scalability and Cost
Testing many genes separately is expensive. IVF with PGT adds significant financial pressure.
Turnaround Time
In pregnancy, time is critical. Delays in results affect important decisions. Labs need fast, reliable, high-capacity methods.
How AlgoBio Can Help
AlgoBio addresses these challenges through two complementary technologies:
Sequence Transduction for High-Throughput Variant Detection
Enables parallel analysis of many genetic markers in a single workflow. This allows comprehensive panels for carrier mutations, aneuploidy, PGT targets, and rare variants. Assay design is fully customizable for prenatal, fertility, or population screening.
Tapestry for Efficient Sample Pooling
Uses combinatorial pooling to test many individuals or embryos efficiently. Each sample is distributed across multiple structured pools, providing built-in confirmation and minimizing false positives.
Key Advantages:
• High-throughput testing with fewer reactions
• Reduced reagent use and lower costs
• Built-in cross-validation increases confidenceThis is ideal for carrier screening, IVF embryo testing, and large prenatal workloads.
Together, these technologies simplify workflows, enabling faster setup, scalable processing, accurate detection, and lower costs—making advanced genetic testing more accessible for clinical decisions.
The Future of Reproductive Genetics
Reproductive genetics is moving from specialized testing to routine clinical practice. Genetic screening before and during pregnancy is likely to become standard, helping families make informed decisions early.
By combining intelligent technology with deep biological insight, AlgoBio offers practical solutions to broaden testing, improve efficiency, and support healthier pregnancies. Sequence Transduction expands variant coverage, while Tapestry enables scalable testing—together, they provide a powerful foundation for the future of reproductive genetics.
More Article
Reproductive Genetics.
Reproductive genetics focuses on the genetic factors that influence fertility, conception, and the health of a developing fetus. It helps answer critical questions: Can a couple pass on a genetic condition? Is a pregnancy at risk for chromosomal abnormalities? How can IVF and embryo selection be optimized?
As maternal age increases and the understanding of inherited diseases improves, this field is becoming essential for preventing disease, reducing complications, and supporting healthier pregnancies.
Available Genetic Approaches
Non-Invasive Prenatal Testing (NIPT)
Analyzes fetal DNA in maternal blood to screen for chromosomal abnormalities.
Diagnostic Procedures (CVS & Amniocentesis)
Confirm genetic findings during pregnancy.
Preimplantation Genetic Testing (PGT)
Checks embryos created through IVF for chromosomal or gene-specific conditions before implantation.
Whole Exome/Genome Sequencing
Reveals underlying mutations in cases of recurrent pregnancy loss or unexplained infertility.
What Makes It Difficult?
Despite rapid advances, reproductive genetics faces major barriers:
Limited Coverage
Most panels test only a selected list of genes, missing rare variants, especially in diverse populations.
Scalability and Cost
Testing many genes separately is expensive. IVF with PGT adds significant financial pressure.
Turnaround Time
In pregnancy, time is critical. Delays in results affect important decisions. Labs need fast, reliable, high-capacity methods.
How AlgoBio Can Help
AlgoBio addresses these challenges through two complementary technologies:
Sequence Transduction for High-Throughput Variant Detection
Enables parallel analysis of many genetic markers in a single workflow. This allows comprehensive panels for carrier mutations, aneuploidy, PGT targets, and rare variants. Assay design is fully customizable for prenatal, fertility, or population screening.
Tapestry for Efficient Sample Pooling
Uses combinatorial pooling to test many individuals or embryos efficiently. Each sample is distributed across multiple structured pools, providing built-in confirmation and minimizing false positives.
Key Advantages:
• High-throughput testing with fewer reactions
• Reduced reagent use and lower costs
• Built-in cross-validation increases confidenceThis is ideal for carrier screening, IVF embryo testing, and large prenatal workloads.
Together, these technologies simplify workflows, enabling faster setup, scalable processing, accurate detection, and lower costs—making advanced genetic testing more accessible for clinical decisions.
The Future of Reproductive Genetics
Reproductive genetics is moving from specialized testing to routine clinical practice. Genetic screening before and during pregnancy is likely to become standard, helping families make informed decisions early.
By combining intelligent technology with deep biological insight, AlgoBio offers practical solutions to broaden testing, improve efficiency, and support healthier pregnancies. Sequence Transduction expands variant coverage, while Tapestry enables scalable testing—together, they provide a powerful foundation for the future of reproductive genetics.